National Medical Care Co. (4005) is listed on Tadawul of the Saudi Exchange (Tadawul) under sector Health Care Equipment & Svc. Financial data sourced from CMA-mandated XBRL filings via Sahm Screener (sahmscreener.com).

For fiscal year 2025, National Medical Care Co. reported revenue of SAR 1.60B, net profit of SAR 318M, and earnings per share of SAR 7.13. Total assets stood at SAR 2.77B with total equity of SAR 1.85B and total liabilities of SAR 922M.

Operating cash flow for 2025 was SAR 154M, representing a cash conversion ratio of 0.48 relative to net profit. Free cash flow was SAR 275M.

Earnings quality analysis by Sahm Screener: Of every SAR 1.00 in reported net profit for 2025, SAR 0.48 arrived as operating cash. This indicates Low quality earnings based on the cash conversion ratio of 0.48.

Revenue growth from 2024 to 2025: +23.7%. Net profit growth over the same period: +6.8%. 3-year revenue CAGR: 36.6%. 3-year net profit CAGR: 23.3%.

Key financial ratios for 2025: Return on Equity 17.2%, Return on Assets 11.5%, Net Margin 19.9%, Debt to Equity 0.50.

In 2024, National Medical Care Co. reported revenue of SAR 1.29B and net profit of SAR 298M, compared to SAR 1.60B and SAR 318M respectively in 2025.